Marco Colombatti
- Biotechnology top 0.5%
- Transgenic Plants and Applications 28
- Immunology top 2%
- Toxin Mechanisms and Immunotoxins 40
- Immunotherapy and Immune Responses 9
- Virology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 21
- Radiopharmaceutical Chemistry and Applications 9
- Oncology top 5%
-
- Prostate Cancer Treatment and Research 9
-
- Glycosylation and Glycoproteins Research 7
-
- Gold and Silver Nanoparticles Synthesis and Applications 7
- Co-authors
- Giulio FracassoGiuseppe TridenteRichard J. YouleMoreno MeneghettiCristina AnselmiSara CingarliniLorenzo MorettaVincenzo Amendola
- Cited by
- BiotechnologyImmunologyVirology
- Journals
- Journal of Biological Chemistry (5 papers)Blood (2 papers)The Journal of Immunology (8 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Marco Colombatti
107 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 125
- Biotechnology 568
- Immunology 1.2k
- Virology 98
- Radiology, Nuclear Medicine and Imaging 470
- Oncology 515
Countries citing papers authored by Marco Colombatti
This map shows the geographic impact of Marco Colombatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Colombatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Colombatti more than expected).
Fields of papers citing papers by Marco Colombatti
This network shows the impact of papers produced by Marco Colombatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Colombatti. The network helps show where Marco Colombatti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marco Colombatti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 15 | |
| 2 | 2019 | 42 | |
| 3 | 2017 | 30 | |
| 4 | 2017 | 18 | |
| 5 | 2015 | 20 | |
| 6 | 2015 | 14 | |
| 7 | Targeting human prostate cancer xenografts with In-111-labeled D2B IgG, F(ab ')2 and Fab fragments in nude mice | 2012 | 0 |
| 8 | 2012 | 14 | |
| 9 | 2011 | 39 | |
| 10 | 2010 | 96 | |
| 11 | 2009 | 89 | |
| 12 | 2009 | 7 | |
| 13 | 2005 | 11 | |
| 14 | 2004 | 58 | |
| 15 | 2002 | 73 | |
| 16 | 2000 | 22 | |
| 17 | 1996 | 6 | |
| 18 | 1995 | 29 | |
| 19 | 1988 | 6 | |
| 20 | Distribution and properties of Fc receptors for IgG on different leucocyte populations in man. | 1981 | 11 |
About Marco Colombatti
Marco Colombatti is a scholar working on Biotechnology, Immunology and Immunology and Allergy, having authored 108 papers that have together received 2.8k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (40 papers), Transgenic Plants and Applications (28 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Immunotherapy and Immune Responses (9 papers), Prostate Cancer Treatment and Research (9 papers), Glycosylation and Glycoproteins Research (7 papers) and Gold and Silver Nanoparticles Synthesis and Applications (7 papers). The work is most often cited by research in Biotechnology (568 citations), Immunology (1.2k citations) and Virology (98 citations). Marco Colombatti has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Giulio Fracasso, Giuseppe Tridente, Richard J. Youle, Moreno Meneghetti, Cristina Anselmi, Sara Cingarlini, Lorenzo Moretta, Vincenzo Amendola, Roberto Chignola and Maria Cristina Mingari. Their work appears in journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.